Estimaciones de analistas de Wall Street para Oramed Pharmaceuticals Inc. (ORMP): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Consenso de analistas
| Compra fuerte | 0 |
| Compra | 6 |
| Mantener | 2 |
| Venta | 0 |
| Venta fuerte | 0 |
| Analistas totales | 8 |
| Calificación media (1-5) | 0.75 |
Ratios de valoración
| Ratio P/E | 1.09 |
| Precio / Valor contable | 0.60 |
| EV / EBITDA | 1.26 |
| Rentabilidad por dividendo | 5.41% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $641000 | $2.5M | $2.4M | $2.7M | $2.7M | $2.7M | $2.7M | $1.3M | 0 | $2.0M |
| Coste de Ventas | $490000 | $187000 | $86000 | $90000 | 0 | 0 | 0 | 0 | 0 | $2.0M |
| Beneficio Bruto | $151000 | $2.3M | $2.4M | $2.6M | $2.7M | $2.7M | $2.7M | $1.3M | 0 | $13000 |
| I+D | $7.7M | $10.3M | $12.0M | $13.5M | $10.2M | $21.0M | $27.6M | $9.0M | $6.3M | $6.4M |
| Generales y Administrativos | $2.5M | $2.8M | $4.1M | $3.7M | $4.2M | $5.9M | $15.7M | $8.1M | $6.5M | $8.7M |
| Gastos Operativos | $10.2M | $13.0M | $16.1M | $17.2M | $14.5M | $26.9M | $43.3M | $17.1M | $12.8M | $15.1M |
| Beneficio Operativo | -$10.0M | -$10.8M | -$13.5M | -$14.6M | -$11.8M | -$24.2M | -$40.6M | -$15.8M | -$12.8M | -$15.1M |
| EBITDA | -$10.0M | -$10.8M | -$13.5M | -$14.2M | -$11.8M | -$24.1M | -$37.0M | $7.3M | -$14.9M | $75.4M |
| Gastos por Intereses | $11000 | $6000 | $6000 | 0 | 0 | 0 | 0 | $3.6M | $853000 | 0 |
| Beneficio Antes de Impuestos | -$9.6M | -$10.1M | -$12.7M | -$14.1M | -$11.5M | -$23.0M | -$37.7M | $5.1M | -$15.9M | $75.3M |
| Impuestos | $1.3M | $400000 | -$800000 | $300000 | 0 | 0 | $100000 | 0 | $3.2M | $11.3M |
| Beneficio Neto | -$11.0M | -$10.5M | -$12.7M | -$14.4M | -$11.5M | -$22.2M | -$37.8M | $5.5M | -$19.1M | $64.0M |
| BPA | $-0.87 | $-0.79 | $-0.86 | $-0.82 | $-0.56 | $-0.78 | $-0.97 | $0.14 | $-0.48 | $1.53 |
| BPA Diluido | $-0.87 | $-0.79 | $-0.86 | $-0.82 | $-0.56 | $-0.78 | $-0.97 | $0.14 | $-0.48 | $1.50 |
| Acciones en Circulación (Diluidas) | $12.6M | $13.3M | $14.9M | $17.5M | $20.5M | $28.5M | $39.0M | $40.6M | $40.9M | $42.4M |
Precio
| Precio | $4.62 |
| Capitalización | $189M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: CLNN · CNTB · CNTX · COYA · IFRX · IMA · KLRS
Explorar sector: Healthcare · Biotechnology
Más secciones de ORMP: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones